Thyroid lobectomy is an effective option for unilateral benign nodular disease. (19th May 2016)

• Record Type: Journal Article
• Authors: Lytrivi, Maria; Kyrilli, Aglaia; Burniat, Agnès; Ruiz Patino, Maria; Sokolow, Youri; Corvilain, Bernard
• Is Part Of: Clinical endocrinology. Volume 85:Number 4(2016)
• Page Start: 602
• Page End: 608
• Publication Date: 2016-05-19
• Subjects: Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.13088
• Languages: English
• ISSNs: 0300-0664

Abstract

Summary: Objective: The use of thyroid lobectomy in the treatment of unilateral, benign nodules is limited by the potential of nodular recurrence in the remaining lobe. This study aimed to assess the rate and clinical impact of nodular recurrence in the contralateral lobe after thyroid lobectomy and to identify predictive factors of recurrence. Design: Single‐centre retrospective study. Patients: Records of patients that underwent lobectomy for unilateral thyroid nodules between 1991 and 2010 were reviewed and 270 patients were included. Exclusion criteria were: presence of contralateral nodule(s) ≥5 mm on preoperative ultrasound, diagnosis of cancer necessitating completion thyroidectomy or pseudonodules. Recurrence was defined as the occurrence of nodule(s) ≥5 mm in the remaining lobe on at least one postoperative ultrasound. A set of clinical, imaging, histological and biochemical parameters was tested as predictors of recurrence using logistic regression. Results: After a median follow‐up of 78 months (range, 12–277 months), the global recurrence rate was 42% and recurrence of nodules of a size ≥1 cm occurred in 19%. Reoperation rate was 1·1%. 90% of patients were treated postoperatively by levothyroxine. Median time to nodular recurrence was 4 years. Preoperative contralateral lobe volume and resected thyroid weight were identified as significant predictors of recurrence ( P = 0·045 and P = 0·03 respectively). Conclusions: Thyroid lobectomy is an effective therapeutic strategy for unilateral, benign nodules, resulting in a low rate of clinically relevant nodular relapse in a mildly iodine‐deficient area. Patients with uninodular disease and a contralateral lobe of normal size are particularly good candidates for lobectomy.